Dr Reddy's Laboratories on Monday announced the commercial launch of anti-COVID-19 oral drug 2DG developed by the Defence Research and Development Organisation (DRDO). The drug will be supplied to major government and private hospitals across India, Dr Reddy's said. The maximum selling price has been capped at Rs990, with a discounted rate offered to government institutions, it said.
 

Dr Reddy's Laboratories on Monday announced the commercial launch of anti-COVID-19 oral drug 2DG developed by the Defence Research and Development Organisation (DRDO). The drug will be supplied to major government and private hospitals across India, Dr Reddy's said. The maximum selling price has been capped at Rs990, with a discounted rate offered to government institutions, it said.